Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)
Status:
Not yet recruiting
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
This study aims to compare the efficacy and safety of reduced adjuvant XELOX treatment (4
cycles of XELOX followed by 4 cycles of capecitabine alone) to standard adjuvant XELOX
treatment (8 cycles of XELOX).